Skip to main content
Journal of Cerebral Blood Flow & Metabolism logoLink to Journal of Cerebral Blood Flow & Metabolism
. 2010 Jun 30;31(2):448–456. doi: 10.1038/jcbfm.2010.106

Prediction of infarct volume and neurologic outcome by using automated multiparametric perfusion-weighted magnetic resonance imaging in a primate model of permanent middle cerebral artery occlusion

Makoto Sasaki 1,*, Kohsuke Kudo 1, Kaneyoshi Honjo 2, Jin-Qing Hu 3, Hai-Bin Wang 4, Katsuya Shintaku 2
PMCID: PMC3049500  PMID: 20588314

Abstract

By optimizing thresholds, we identified the perfusion-weighted magnetic resonance imaging (PWI) parameters that accurately predict final infarct volume and neurologic outcome in a primate model of permanent middle cerebral artery (MCA) occlusion. Ten cynomolgus monkeys underwent PWI and diffusion-weighted imaging (DWI) at 3 and 47 hours, respectively, after right MCA occlusion using platinum coils, and were killed at 48 hours. Volumes of the hypoperfused areas on PWI were automatically measured using different thresholds and 11 parametric maps to determine the optimum threshold (at which least difference was found between the average volumes on PWI and those determined using specimens or DWI). In the case of arrival time (AT), cerebral blood volume (CBV), time to peak (TTP), time to maximum (Tmax), and cerebral blood flow (CBF) determined using deconvolution techniques, the volume of the hypoperfused area significantly correlated with the infarct volumes and the neurologic deficit scores with small variations, whereas in the case of mean transit time and nondeconvolution CBF, relatively poor correlations with large variations were seen. At optimum threshold, AT, CBV, TTP, Tmax, and deconvolution CBF can accurately predict the final infarct volume and neurologic outcome in monkeys with permanent MCA occlusion.

Keywords: acute stroke, animal studies, brain imaging, cerebral blood flow measurement, perfusion-weighted MRI

Introduction

Perfusion-weighted magnetic resonance imaging (MRI) (PWI) by using the dynamic susceptibility contrast method is widely used to assess perfusion abnormalities in patients with acute ischemic stroke, including candidates for thrombolytic therapies. It has been considered that PWI combined with diffusion-weighted imaging (DWI) can predict which tissues with ischemic penumbra can be salvaged by immediate reperfusion therapy, particularly, beyond 3 hours after the onset of ischemia (Albers et al, 2006; Davis et al, 2008; Koehrmann et al, 2007). However, several studies have reported that areas with perfusion abnormalities show significant variations depending on the parameters, algorithms, or thresholds used to evaluate the abnormalities (Wirestam et al, 2000; Kane et al, 2007; Kudo et al, 2009, 2010). These inconsistencies associated with PWI seem to be one of the reasons for the failure of a recent randomized trial on intravenous thrombolytic therapy, in which a PWI-DWI mismatch had unprecedentedly been adopted as an inclusion criterion (Hacke et al, 2009). To resolve the inconsistencies in PWI findings, it is essential to determine the most appropriate PWI conditions for accurate prediction of penumbral areas. Therefore, we attempted to determine the parameter, algorithm, and threshold that accurately predict the infarct volume and neurologic outcome after permanent unilateral occlusion of the middle cerebral artery (MCA) in the primate brain.

Materials and methods

Preparation of Animal Model

From June to September 2008, we performed intravascular surgery on 10 male cynomolgus monkeys (Macaca fascicularis) to prepare a model of permanent unilateral MCA occlusion. The preoperative body weights and ages of the animals were 4.72 to 5.61 kg (mean, 5.17 kg) and 46 to 56 months (mean, 50.4 months), respectively. The monkeys were anesthetized with an intravenous injection of pentobarbital sodium (20 mg/kg) after an intramuscular injection of ketamine hydrochloride (10 mg/kg) containing atropine sulfate (0.05 mg/kg) before the surgery, which was performed by one of the authors (JH). A 4-F vascular sheath was inserted into the right femoral artery, and a 4-F guiding catheter was positioned into the right internal carotid artery under the guidance of a 0.035-inch guidewire. A 2.3-F or 1.7-F microcatheter with a microguidewire was then coaxially inserted through the guiding catheter and positioned in the proximal part of the horizontal (M1) portion of the right MCA. Finally, a 2 mm × 4 cm Guglielmi detachable coil (Boston Scientific, Natick, MA, USA) was placed in the M1 portion. Complete occlusion of the MCA was confirmed by digital subtraction angiography through the guiding catheter.

All study procedures were approved by the institutional animal care and use committee and performed in accordance with the institutional guidelines for animal experiments.

Magnetic Resonance Imaging

Baseline and follow-up MRI examinations were performed ∼3 and 47 hours after MCA occlusion, respectively, by using a 1.5-T MR scanner (Signa MR/i; GE Healthcare, Milwaukee, WI, USA) and a quadrature detection knee coil. One animal died 22 hours after MCA occlusion and was subjected to the follow-up MRI immediately after death (at 22 hours after MCA occlusion). All the animals were anesthetized with an intramuscular injection of ketamine hydrochloride (10 mg/kg) containing atropine sulfate (0.05 mg/kg) before the MRI examinations.

The baseline MRI comprised axial single-shot spin-echo echo-planar DWI (repetition time/echo time, 8000 milliseconds/60 milliseconds; b-value, 1000 sec/mm2) and axial single-shot gradient-echo echo-planar PWI (repetition time/echo time/flip angle, 800 milliseconds/20 milliseconds/20°). For PWI, 0.8 mL/kg gadolinium-diethylenetriamine pentaacetic acid (Magnevist; Bayer Schering Pharma, Berlin, Germany) followed by saline (1.5 mL/kg) was injected into the left saphenous vein at a flow rate of 2 mL/sec by using a power injector. The injection was started 15 seconds after initiating dynamic imaging (frames, 30; time resolution, 2 seconds; total acquisition time, 60 seconds). T2-weighted images (repetition time/echo time, 3000 milliseconds/100 milliseconds) and fluid-attenuated inversion recovery images (repetition time/inversion time/echo time, 7000 milliseconds/2100 milliseconds/140 milliseconds) were also obtained before performing PWI. Other imaging parameters were as follows: matrix size, 128 × 128 (for DWI and PWI) and 256 × 256 (for T2-weighted images and fluid-attenuated inversion recovery images); field of view, 20 cm; and slice thickness, 4 mm with 1.5-mm interslice gaps.

The follow-up MRI performed at 47 hours after MCA occlusion comprised axial and coronal DWI as well as axial T2-weighted images and fluid-attenuated inversion recovery images performed using the aforementioned parameters.

Neurologic Examination

To evaluate the neurologic outcome after permanent MCA occlusion, we calculated the neurologic deficit score (NDS) for monkeys by using a modification of the scoring method introduced by Kito et al (2001) (Table 1) at 46 hours after MCA occlusion, that is, just before the follow-up MRI. The consciousness, sensory system, motor system, and skeletal muscle coordination of the monkeys was assessed by one of the authors (KS), who had extensive experience in evaluating NDSs and was unaware of the baseline MRI findings. The animal that died 22 hours after MCA occlusion could not be subjected to a neurologic evaluation.

Table 1. Neurologic deficit score for monkeys.

Category Score
Consciousness (range, 0–28)
 Normal, consistently alert 0
 Conscious and aggressive 4
 Conscious and evasive 6
 Conscious but slow response 8
 Drowsy, aroused with stimulation 10
 Lethargic, eyes open by intense stimulation 16
 Stupor, aroused with persistent stimulation 20
 Light coma, reflexive movements only 24
 Deep coma, no movement 28
   
Sensory system (range, 0–11; contralateral to ischemic lesion)
Facial sensation
  Normal: reacts consistently to touch on any area of the face 0
  Absent: does not react to touch on any area of the face 3
Pinna reflex
  Normal: responds to ear twitching 0
  Absent: does not respond to ear twitching 3
Pain reflex
  Normal: complete withdrawal from toe pinch 0
  Strong: quick but incomplete withdrawal from toe pinch 1
  Weak: slow or inconsistent withdrawal from toe pinch 3
  Absent: no withdrawal from toe pinch 5
   
Motor system (range, 0–16; contralateral to ischemic lesion)
Upper limb (grasp and movement)
  Normal 0
  Reduced strength and disharmonious movement
   Mild 1
   Moderate 2
   Severe 3
   Paralyzed and cannot grasp 4
Lower limb (grasp and movement)
  Normal 0
  Raised with flexion of the knee
   Mild 1
   Moderate 2
   Severe 3
  Can move but cannot raise 4
  Paralyzed and cannot move 6
Upper limb tone
  Normal 0
  Overtly spastic or flaccid 3
Lower limb tone
  Normal 0
  Overtly spastic or flaccid 3
   
Skeletal muscle coordination (range, 0–18)
 Normal, walks normally 0
 Minimal ataxia, walks with some gait impairment 4
 Ataxia, can climb a perch 6
 Ataxia, cannot climb a perch 8
 Stands independently, dysbasia 10
 Sits, only able to circle on stimulation 12
 Posed with lateral or dorsal recumbency 16
 No movement 18

Histologic Preparation and Analysis

The animals were deeply anesthetized with an intravenous injection of pentobarbital sodium (35 mg/kg) 48 hours after MCA occlusion. The entire brain was excised, and contiguous coronal sections were cut at 4-mm intervals by using a brain matrix meant for the dissection of adult monkey brains (MBM-2000C; BioResearch, Nagoya, Japan). The sections were stained with 1% 2,3,5-triphenyltetrazolium chloride and transferred to a 10% formalin neutral buffer solution.

The 2,3,5-triphenyltetrazolium chloride-stained sections, in which healthy tissue was stained red and infarcted tissue appeared white, were digitized with a scanner at a resolution of 300 dots per inch. The infarcted areas in each coronal section were manually traced by one of the authors (KH) by using an image analysis software package (SimplePCI Ver. 5.2; Hamamatsu Corporation, Sewickley, PA, USA), and the infarct volumes were calculated.

Perfusion-Weighted Magnetic Resonance Imaging Data Analysis

Postprocessing of the PWI data was performed using a free PWI analysis software package (Perfusion Mismatch Analyzer [PMA] Ver. 3.0.0.0; Acute Stroke Imaging Standardization Group-Japan; http://asist.umin.jp/index-e.htm). After automatic detection of the arterial input function and venous output function, classical and semiquantitative parametric maps were simultaneously generated. The latter were prepared using two types of deconvolution techniques, namely, standard singular value decomposition (sSVD) and block-circulant singular value decomposition (bSVD). Classical parametric maps of the following parameters were drawn: arrival time (AT), time to peak (TTP), mean transit time (MTT) calculated using the first moment (FM) method, cerebral blood flow (CBF) determined using the maximum slope method, and cerebral blood volume (CBV) calculated on the basis of area under the curve. Semiquantitative parametric maps generated using sSVD and bSVD included the following parameters: CBF determined as the peak value of residue function (R(t)), MTT calculated by dividing the area under the curve of R(t) by CBF, and time to maximum of R(t) (Tmax).

By using the software mentioned above, the volumes of the areas showing perfusion abnormalities were automatically measured after establishing a seed point within the lesion area, under different thresholds of the contralateral ratio, which ranged from 1 to 6 with intervals of 0.02 (300 steps) in the AT, TTP, MTT, and Tmax maps and from 0 to 1 with intervals of 0.01 (100 steps) in the CBF and CBV maps. The volumes of the areas showing diffusion abnormalities on follow-up axial and coronal DWI were also measured using the methods mentioned above.

Statistical Analyses

Pearson's correlation test was used to assess the correlation between infarct volume and the volume of areas with perfusion abnormalities, as measured using the appropriate threshold at which the average volume of the latter showed minimum difference from that of the former. Further, agreements between the values calculated above were determined by calculating the intraclass correlation coefficient (ICC). The correlation between the NDS value and hypoperfused volume of the PWI maps was also examined by Spearman's rank correlation test. The α level for all the analyses was 0.05.

Results

Baseline and follow-up MR images with sufficient image quality were successfully obtained for all the animals, and all the PWI data were readily analyzed by the Perfusion Mismatch Analyzer software.

The volumes of hyperintense areas on the follow-up axial and coronal DWI showed very high correlations and agreements (axial DWI: r=0.98, ICC=0.91; coronal DWI: r=0.96, ICC=0.94) with those of the infarcts in the coronal sections (Table 2), when the threshold of the contralateral ratio was set such that the average volume of the hyperintense areas on coronal DWI showed minimum difference from the infarct volumes in the coronal specimens, that is, 1.75 (Figures 1 and 2). This indicated the relevance of axial and coronal DWI as a surrogate marker for infarct volume.

Table 2. Infarct volumes and clinical outcomes in animals with permanent occlusion of unilateral MCA.

Animal Body weight (kg) Infarct volume (cm3)
Neurologic deficit score for monkeys
    Specimen (TTC stained) Coronal DWI (contralateral ratio>1.75) Axial DWI  
1 5.39 3.88 2.95 6.93 34
2 5.52 3.73 1.16 5.29 35
3 4.72 2.25 2.80 3.34 26
4 5.36 3.21 3.62 5.18 23
5 4.87 9.24 12.01 15.34 47
6 5.61 7.75 10.16 12.54 43
7 4.93 2.58 2.23 6.46 27
8 4.89 6.39 4.74 7.22 35
9 5.56 16.39 17.67 23.88
10 4.84 1.67 1.83 2.59 22
Mean (s.d.) 5.17 (0.11) 5.71 (4.51) 5.92 (5.49) 8.88 (6.58) 34 (14.5)
r     0.96* 0.98*  
ICC     0.94* 0.91*  

DWI, diffusion-weighted imaging; ICC, intraclass correlation coefficient; MCA, middle cerebral artery; r, correlation coefficient; TTC, 2,3,5-triphenyltetrazolium chloride.

*P<0.001; died at 22 h after MCA occlusion; median (interquartile range).

Figure 1.

Figure 1

Determination of the optimum thresholds at which the average volume of the hypoperfused areas showed minimum difference from that of the infarct areas. CR represents contralateral ratio of the signal intensity of the hypoperfused area; VR represents average volume ratio of the hypoperfused area to the infarct area; blue lines represent VR against the specimen; and red lines represent VR against the axial diffusion-weighted imaging (DWI) with the threshold at a CR of 1.75. Optimum thresholds were determined at a VR of 1.0. AT, arrival time; bSVD, block-circulant singular value decomposition; CBF, cerebral blood flow; CBV, cerebral blood volume; FM, first moment; MTT, mean transit time; MS, maximum slope; sSVD, standard singular value decomposition; Tmax, time to maximum; TTP, time to peak.

Figure 2.

Figure 2

Multiparametric perfusion-weighted images, diffusion-weighted images, and macroscopic pathologic images (subject #1). Purple areas on perfusion-weighted magnetic resonance imaging (PWI) in the middle and lower rows: hypoperfused areas that were automatically determined using the threshold at which the average volume of the hypoperfused area showed minimum difference from that of the infarct areas on the specimen and axial diffusion-weighted imaging (DWI), respectively. Red areas on DWI represent abnormal signal areas that were automatically determined using the threshold at which the average volume of the abnormal area on coronal DWI showed minimum difference from that of the specimen. Hypoperfusion areas remarkably vary among various metrics of PWI. Those on the arrival time (AT), block-circulant singular value decomposition (bSVD)-time to maximum (Tmax), bSVD-cerebral blood flow (CBF), and cerebral blood volume (CBV) maps were comparable with the infarct area. FM, first moment; MTT, mean transit time; MS, maximum slope; sSVD, standard singular value decomposition; TTP, time to peak.

The volumes of the hypoperfused areas in the AT and CBV maps showed excellent correlations (P<0.001) and agreements (P<0.01) with those of the infarcts in the coronal specimens (r=0.91 and ICC=0.78 in both AT and CBV maps) at a threshold at which the average volume of the hypoperfused areas showed minimum difference from that of the infarcts in the coronal specimens (Figures 1 and 2; Table 3). Further, the volumes of the hypoperfused areas in the TTP, bSVD-Tmax, sSVD-CBF, and bSVD-CBF maps showed strong correlations (P<0.01) and agreements (P<0.01 for the TTP map and bSVD-Tmax; P<0.05 for the sSVD-CBF and bSVD-CBF maps) with those of the infarcts (r=0.88, 0.80, 0.83, and 0.88, respectively; ICC=0.82, 0.70, 0.61, and 0.58, respectively). On the other hand, the volumes of the hypoperfused areas in the sSVD-MTT, bSVD-MTT, sSVD-Tmax, and maximum slope-CBF maps showed fair correlations (P<0.05) with those of the infarcts (r=0.68, 0.70, 0.73, and 0.75, respectively), whereas no significant correlation or agreement was observed in the case of the FM-MTT map (Figures 1 and 2; Table 3).

Table 3. Relationship between hypoperfused volume on different PWI parameters and infarction volume or clinical outcome in animals with permanent occlusion of unilateral MCA.

PWI parameter Algorithm Correlation with infarct volume in specimens
Correlation with infarct volume in axial DWI
Correlation with NDS
    Threshold Volume ratio r ICC Threshold Volume ratio r ICC ρ
AT   >1.42 1.01 (0.40) 0.91 0.78 >1.28 1.00 (0.49) 0.73* 0.45 0.86
TTP   >1.40 0.96 (0.44) 0.88 0.82 >1.28 1.00 (0.52) 0.73* 0.55* 0.82*
MTT FM >1.21 1.01 (1.10) 0.39 0.33 >1.16 1.00 (1.06) 0.23 0.16 −0.69
  sSVD >1.53 1.01 (0.59) 0.68* 0.41 >1.42 1.04 (0.69) 0.45 0.22 0.18
  bSVD >1.29 1.08 (0.62) 0.70* 0.51 >1.22 1.06 (0.60) 0.62 0.32 0.67
Tmax sSVD >2.50 1.01 (0.66) 0.73* 0.70 >1.50 1.02 (0.55) 0.62 0.49 0.59
  bSVD >5.00 1.02 (0.52) 0.80 0.70 >3.20 0.98 (0.51) 0.66* 0.50 0.71*
CBF MS <0.42 1.03 (0.50) 0.75* 0.50 <0.48 1.04 (0.56) 0.60 0.31 0.36
  sSVD <0.29 1.00 (0.44) 0.83 0.61* <0.35 0.98 (0.46) 0.64* 0.37 0.71*
  bSVD <0.32 0.96 (0.39) 0.88 0.58* <0.39 0.99 (0.48) 0.75* 0.35 0.89
CBV AUC <0.37 0.99 (0.40) 0.91 0.78 <0.47 0.99 (0.38) 0.78 0.50 0.75*

AT, arrival time; AUC, area under the curve; bSVD, block-circulant singular value decomposition; CBF, cerebral blood flow; CBV, cerebral blood volume; DWI, diffusion-weighted imaging; FM, first moment; ICC, intraclass correlation coefficient; MCA, middle cerebral artery; MS, maximum slope; MTT, mean transit time; NDS, neurologic deficit score for monkeys; PWI, perfusion-weighted imaging; r, correlation coefficient; ρ, Spearman's rank correlation coefficient; sSVD, standard singular value decomposition; Tmax, time to maximum of residue function; TTP, time to peak.

*P<0.05; P<0.01; P<0.001; at the thresholds at which the average volume of the hypoperfused areas showed minimum difference from that of the infarcts in the specimens.

Further, the volumes of the hypoperfused areas in the AT, TTP, bSVD-Tmax, sSVD-CBF, bSVD-CBF, and CBV maps showed significant correlations (P<0.05; CBV map, P<0.01) with those of the hyperintense areas in the axial DWI (r=0.73, 0.73, 0.66, 0.64, 0.75, and 0.78, respectively). However, no significant agreements were noted, except in the case of the TTP map (Figures 1 and 2; Table 2).

With regard to the neurologic outcome, the volumes of the hypoperfused areas in the AT and bSVD-CBF maps at the thresholds of minimum difference from the infarct volumes of specimens showed good correlations (P<0.01) with the NDS values (ρ=0.86 and 0.89, respectively). The volumes in the TTP, bSVD-Tmax, sSVD-CBF, and CBV maps also correlated significantly with the NDS values (P<0.05) (ρ=0.82, 0.71, 0.71, and 0.75, respectively).

Discussion

The PWI can facilitate the generation of various parametric maps to evaluate cerebral perfusion abnormalities in patients with acute stroke. Earlier studies on thrombolytic therapies have adopted one or several parameters of classical parametric maps such as TTP, MTT calculated by the FM method, CBF determined by the maximum slope method, and CBV calculated on the basis of area under the curve as well as semiquantitative parametric maps such as MTT, CBF, and Tmax calculated using deconvolution techniques (Hjort et al, 2005; Rivers et al, 2006). Considerable variations exist in the extent of perfusion abnormalities determined using these parameters (Wirestam et al, 2000; Kane et al, 2007; Kudo et al, 2009, 2010), and the most reliable parameter and algorithm for evaluating ischemic penumbra and predicting the final infarct volume or patient outcome remain controversial.

In most studies that used PWI for evaluating perfusion abnormalities in acute stroke, hypoperfused areas were visually identified on the basis of color or gray-scale maps without setting any thresholds. Further, recent multicenter trials adopted an ‘eyeballing' method to determine the presence of a >20% PWI-DWI mismatch and accepted the use of any of PWI parameters (Hacke et al, 2005, 2009; Furlan et al, 2006); this decision presumably caused substantial discrepancies among the findings of different institutes, and the indications for thrombolytic therapy were thus unclear. Several studies have performed quantitative assessments by using certain thresholds. Recent trials conducted using Tmax with the threshold set at ≥2 seconds showed that PWI has the potential to predict the outcome of patients receiving thrombolytic therapy (Albers et al, 2006; Davis et al, 2008). Further, Tmax with strict thresholds, for example, 4 to 6 seconds, has been reported to be quite appropriate for predicting penumbral tissue (Olivot et al, 2009). Several studies have comprehensively compared various parameters under different threshold settings (Shih et al, 2003; Sobesky et al, 2004; Butcher et al, 2005; Bandera et al, 2006; Takasawa et al, 2008); however, some principal parameters, algorithms, or both had not been included in these studies. Hence, we compared 11 types of parametric maps generated using various parameters and algorithms after optimizing the thresholds at which best agreement was observed with infarct volume.

In this study, we used a primate model of permanent M1 occlusion instead of patients with acute stroke to avoid intersubject variations in hemodynamics and recanalization and to elucidate susceptibility to errors caused by tracer delay and dispersion effects that are reported to be profound under conditions of major artery occlusion (Calamante et al, 2000). Reperfusion therapy is strongly indicated for acute stroke because of embolic occlusion of the MCA, because early reperfusion has the potential to salvage extensive brain tissues, including several eloquent areas, and to prevent severe neurologic impairments such as hemiplegia and aphasia. However, large intersubject variations in collateral circulation and cerebrovascular reactivity exist under the condition of MCA occlusion and can cause considerable variation in estimating the severity of ischemia, final infarct size, and neurologic outcome. In addition, this condition can produce negligible errors in PWI, usually overestimation of the severity, extent, or both of hypoperfusion, because of tracer delay and dispersion effects because of collateral circulation (Ibaragi et al, 2005). Hence, it is crucial to determine the combination of the parameter, algorithm, and threshold that can most accurately predict the final infarct size and neurologic outcome under the condition of permanent MCA occlusion, because this combination is assumed to be capable of identifying the outer border of the penumbral area in acute stroke.

In this study, the correlations and agreements of the volumes of hypoperfused areas with the infarct volumes and neurologic outcomes remarkably differed with the different PWI parameters and algorithms, despite the strict application of the thresholds optimized using our automated optimization technique. In contrast to earlier observations of acute stroke patients by using PWI (Butcher et al, 2005; Takasawa et al, 2008) or perfusion CT (Wintermark et al, 2006), the volumes of the hypoperfused areas in the AT and CBV maps, which are known to over- and underestimate the final infarct volume, respectively, showed the strongest correlations and agreements with the infarct volumes in the specimens, followed by the TTP, Tmax, and deconvolution-CBF maps. Further, poor or fair correlations and agreements were observed in the case of the MTT calculated using the deconvolution and nondeconvolution methods and the nondeconvolution CBF, although these parameters are believed to be considerably reliable (Takasawa et al, 2008; Wintermark et al, 2006). In addition, the correlations between the volumes of the hypoperfused areas and values of NDS showed the same tendencies as those of the aforementioned correlations. These results suggest that the parameters that accurately visualize penumbral areas and predict final infarct size and neurologic outcome under optimized threshold settings were not identical to those that were considered appropriate on visual examination. The AT, CBV, and TTP, and probably Tmax and deconvolution CBF seem to be more stable and reproducible parameters than the other parameters tested, presumably because of the simplicity of measurement, robustness to noise, and/or the capability to avoid biases during postprocessing, such as tracer delay effects.

Regarding the difference in the algorithms for calculating MTT, CBF, and Tmax, the deconvolution algorithms showed stronger correlations and agreements between the volumes of the hypoperfused areas and those of the infarcts than the nondeconvolution algorithms. Further, bSVD showed stronger correlations and agreements than sSVD. These results suggest that deconvolution algorithms are more reliable than nondeconvolution algorithms, and that bSVD is more accurate than sSVD, as reported earlier (Ostergaard et al, 1996a, 1996b; Wu et al, 2003). More importantly, this study showed that the thresholds remarkably varied among different algorithms, suggesting that quantitative measurement of the penumbral tissue at a specific threshold should be performed after specifying the algorithm used.

In earlier studies, optimum thresholds were determined by comparing two to several threshold settings (Shih et al, 2003; Sobesky et al, 2004; Butcher et al, 2005; Bandera et al, 2006; Takasawa et al, 2008; Olivot et al, 2009). For precise determination of the optimum threshold, we applied a new objective approach. By using a macro function of the Perfusion Mismatch Analyzer software, the volumes of the hypoperfused areas were automatically calculated under serial cutoff values with a wide range and small intervals. By this method, we could easily and objectively determine the threshold at which differences between the volumes of hypoperfused areas and those of the infarcts were minimum. This method can be applied to optimize thresholds of PWI parameters in animal models as well as in the case of patients with acute stroke and may help in determining the most appropriate parameter, algorithm, and threshold in preclinical animal experiments, multicenter trials, and clinical practice.

This study had some limitations. First, the planes used for PWI and specimen preparation differed. Templates for dissection of the primate are provided only for coronal sections, whereas PWI should be performed on axial sections. This limitation may have produced substantial errors on analyses, although the volumes of the infarcts in the coronal specimens showed excellent correlations and agreements with the volumes measured using both coronal and axial follow-up DWI. Second, the volumes of the infarcts in the specimens and on DWI were calculated 2 days after MCA occlusion as it is difficult for our primate model to survive for >3 to 5 days owing to the risk of brain herniation because of the limited intracranial space. In fact, one monkey died before 24 hours. Although a recent report has shown that DWI findings at 3 to 5 days after onset may be a surrogate marker for the final infarct volume (Lu et al, 2005), the final infarct volume is usually assessed by MRI at ≥30 days after onset (Gaudinski et al, 2008). Hence, the calculation of the volumes of the infarcts in the specimens and on DWI at 2 days after onset in this study includes some potential biases caused by infarct evolution after 2 days. The relatively low correlations between the volume of the hypoperfused area on PWI and lesion volume on DWI in this study can be attributed to the fact that lesions on DWI at 2 days after the occlusion cannot directly indicate the infarct volume, although we confirmed strong correlations between the lesion volume on DWI and the infarct volume on the specimens. Third, the number of the subjects was small, and subjects with recanalization and those with occlusions at various locations were not examined. The permanent proximal M1 occlusion that we performed only represents a small subgroup of the ischemic stroke cases, and provides wide ischemic areas such that any perfusion parameters would detect any correlation. Fourth, the time resolution of PWI that we used was relatively low because of a limited hardware performance, which may impede the accuracies of perfusion parameters in the monkeys in which transit time of the tracer within the brain is shorter than in the human subjects. Finally, the thresholds in this study cannot be directly applied for the evaluation of perfusion abnormalities in patients with acute stroke. The thresholds applied in this study were determined using the contralateral ratio and considerably differed from the thresholds used in earlier studies on acute stroke patients (Shih et al, 2003; Sobesky et al, 2004; Butcher et al, 2005; Bandera et al, 2006; Takasawa et al, 2008; Olivot et al, 2009). To determine the optimum parameter, algorithm, and threshold for predicting the final infarct volume in patients with acute stroke, further studies using patient data and the postprocessing technique introduced by us are needed.

In conclusion, this study showed that AT and CBV as well as TTP, Tmax, and CBF determined using deconvolution methods can be used to accurately predict the infarct volume and neurologic outcome in a primate model of permanent MCA occlusion by applying an optimum threshold that is automatically determined.

MS is a consultant for Mitsubishi Tanabe Pharma.

Footnotes

This work was partly supported by a grant from Mitsubishi Tanabe Pharma and by a Grant-in-Aid for Strategic Medical Science Research Center from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.

References

  1. Albers GW, Thijs VN, Wechsler L, Kemp S, Schlaug G, Skalabrin E, Bammer R, Kakuda W, Lansberg MG, Shuaib A, Coplin W, Hamilton S, Moseley M, Marks MP. Magnetic resonance imaging profiles predict clinical response to early reperfusion: the diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study. Ann Neurol. 2006;60:508–517. doi: 10.1002/ana.20976. [DOI] [PubMed] [Google Scholar]
  2. Bandera E, Botteri M, Minelli C, Sutton A, Abrams KR, Latronico N. Cerebral blood flow threshold of ischemic penumbra and infarct core in acute ischemic stroke: a systematic review. Stroke. 2006;37:1334–1339. doi: 10.1161/01.STR.0000217418.29609.22. [DOI] [PubMed] [Google Scholar]
  3. Butcher KS, Parsons M, MacGregor L, Barber PA, Chalk J, Bladin C, Levi C, Kimber T, Schultz D, Fink J, Tress B, Donnan G, Davis S. Refining the perfusion-diffusion mismatch hypothesis. Stroke. 2005;36:1153–1159. doi: 10.1161/01.str.0000166181.86928.8b. [DOI] [PubMed] [Google Scholar]
  4. Calamante F, Gadian DG, Connelly A. Delay and dispersion effects in dynamic susceptibility contrast MRI: simulations using singular value decomposition. Magn Reson Med. 2000;44:466–473. doi: 10.1002/1522-2594(200009)44:3<466::aid-mrm18>3.0.co;2-m. [DOI] [PubMed] [Google Scholar]
  5. Davis SM, Donnan GA, Parsons MW, Levi C, Butcher KS, Peeters A, Barber PA, Bladin C, De Silva DA, Byrnes G, Chalk JB, Fink JN, Kimber TE, Schultz D, Hand PJ, Frayne J, Hankey G, Muir K, Gerraty R, Tress BM, Desmond PM. Effects of alteplase beyond 3 hours after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial. Lancet Neurol. 2008;7:299–309. doi: 10.1016/S1474-4422(08)70044-9. [DOI] [PubMed] [Google Scholar]
  6. Furlan AJ, Eyding D, Albers GW, Al-Rawi Y, Lees KR, Rowley HA, Sachara C, Soehngen M, Warach S, Hacke W. Dose escalation of desmoteplase for acute ischemic stroke (DEDAS): evidence of safety and efficacy 3 to 9 hours after stroke onset. Stroke. 2006;37:1227–1231. doi: 10.1161/01.STR.0000217403.66996.6d. [DOI] [PubMed] [Google Scholar]
  7. Gaudinski MR, Henning EC, Miracle A, Luby M, Warach S, Latour LL. Establishing final infarct volume: stroke lesion evolution past 30 days is insignificant. Stroke. 2008;39:2765–2768. doi: 10.1161/STROKEAHA.107.512269. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Hacke W, Albers G, Al-Rawi Y, Bogousslavsky J, Davalos A, Eliasziw M, Fischer M, Furlan A, Kaste M, Lees KR, Soehngen M, Warach S. The desmoteplase in acute ischemic stroke trial (DIAS): a phase II MRI-based 9-hours window acute stroke thrombolysis trial with intravenous desmoteplase. Stroke. 2005;36:66–73. doi: 10.1161/01.STR.0000149938.08731.2c. [DOI] [PubMed] [Google Scholar]
  9. Hacke W, Furlan AJ, Al-Rawi Y, Davalos A, Fiebach JB, Gruber F, Kaste M, Lipka LJ, Pedraza S, Ringleb PA, Rowley HA, Schneider D, Schwamm LH, Leal JS, Söhngen M, Teal PA, Wilhelm-Ogunbiyi K, Wintermark M, Warach S. Intravenous desmoteplase in patients with acute ischaemic stroke selected by MRI perfusion-diffusion weighted imaging or perfusion CT (DIAS-2): a prospective, randomised, double-blind, placebo- controlled study. Lancet Neurol. 2009;8:126–128. doi: 10.1016/S1474-4422(08)70267-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Hjort N, Butcher K, Davis SM, Kidwell CS, Koroshetz WJ, Röther J, Schellinger PD, Warach S, Ostergaard L. Magnetic resonance imaging criteria for thrombolysis in acute cerebral infarct. Stroke. 2005;36:388–397. doi: 10.1161/01.STR.0000152268.47919.be. [DOI] [PubMed] [Google Scholar]
  11. Ibaragi M, Shimosegawa E, Toyoshima H, Takahashi K, Miura S, Kanno I. Tracer delay correction of cerebral blood flow with dynamic susceptibility contrast-enhanced MRI. J Cereb Bood Flow Metab. 2005;25:378–390. doi: 10.1038/sj.jcbfm.9600037. [DOI] [PubMed] [Google Scholar]
  12. Kane I, Carpenter T, Chappell F, Rivers C, Armitage P, Sandercock P, Wardlaw J. Comparison of 10 different magnetic resonance perfusion imaging processing methods in acute ischemic stroke: effect on lesion size, proportion of patients with diffusion/perfusion mismatch, clinical scores, and radiologic outcomes. Stroke. 2007;38:3158–3164. doi: 10.1161/STROKEAHA.107.483842. [DOI] [PubMed] [Google Scholar]
  13. Kito G, Nishimura A, Susumu T, Nagata R, Kuge Y, Yokota C, Minematsu K. Experimental thromboembolic stroke in cynomolgus monkey. J Neurosci Methods. 2001;105:45–53. doi: 10.1016/s0165-0270(00)00351-4. [DOI] [PubMed] [Google Scholar]
  14. Koehrmann M, Juettler E, Huttner H, Nowe T, Schellinger PD. Acute stroke imaging for thrombolytic therapy—an update. Cerebrovasc Dis. 2007;24:161–169. doi: 10.1159/000104473. [DOI] [PubMed] [Google Scholar]
  15. Kudo K, Sasaki M, Ogasawara K, Terae S, Ehara S, Shirato H. Difference in tracer delay effect among deconvolution algorithms in CT perfusion analysis: quantitative evaluation by using digital phantom. Radiology. 2009;251:241–249. doi: 10.1148/radiol.2511080983. [DOI] [PubMed] [Google Scholar]
  16. Kudo K, Sasaki M, Yamada K, Momoshima S, Utsunomiya H, Shirato H, Ogasawara K. Differences in CT perfusion maps generated by different commercial software: quantitative analysis by using identical source data of acute stroke patients. Radiology. 2010;254:200–209. doi: 10.1148/radiol.254082000. [DOI] [PubMed] [Google Scholar]
  17. Lu M, Mitsias PD, Ewing JR, Soltanian-Zadeh H, Bagher-Ebadian H, Zhao Q, Oja-Tebbe N, Patel SC, Chopp M. Predicting final infarct size using acute and subacute multiparametric MRI measurements in patients with ischemic stroke. J Magn Reson Imaging. 2005;21:495–502. doi: 10.1002/jmri.20313. [DOI] [PubMed] [Google Scholar]
  18. Olivot JM, Mlynash M, Thijs VN, Kemp S, Lansberg MG, Wechsler L, Bammer R, Marks MP, Albers GW. Optimal Tmax threshold for predicting penumbral tissue in acute stroke. Stroke. 2009;40:469–475. doi: 10.1161/STROKEAHA.108.526954. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Ostergaard L, Sorensen AG, Kwong KK, Weisskoff RM, Gyldensted C, Rosen BR. High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part II. Experimental comparison and preliminary results. Magn Reson Med. 1996a;36:726–736. doi: 10.1002/mrm.1910360511. [DOI] [PubMed] [Google Scholar]
  20. Ostergaard L, Weisskoff RM, Chesler DA, Gyldensted C, Rosen BR. High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part I. Mathematical approach and statistical analysis. Magn Reson Med. 1996b;36:715–725. doi: 10.1002/mrm.1910360510. [DOI] [PubMed] [Google Scholar]
  21. Rivers CS, Wardlaw JM, Armitage PA, Bastin ME, Carpenter TK, Cvoro V, Hand PJ, Dennis MS. Do acute diffusion- and perfusion-weighted MRI lesions indentify final infarct volume in ischemic stroke. Stroke. 2006;37:98–104. doi: 10.1161/01.STR.0000195197.66606.bb. [DOI] [PubMed] [Google Scholar]
  22. Shih LC, Saver JL, Alger JR, Starkman S, Leary MC, Vinuela F, Duckwiler G, Gobin YP, Jahan R, Villablanca JP, Vespa PM, Kidwell CS. Perfusion-weighted magnetic resonance imaging thresholds identifying core, irreversibly infarcted tissue. Stroke. 2003;34:1425–1430. doi: 10.1161/01.STR.0000072998.70087.E9. [DOI] [PubMed] [Google Scholar]
  23. Sobesky J, Weber Z, Lehnhardt FG, Hesselmann V, Thiel A, Dohmen C, Jacobs A, Neveling M, Heiss WD. Which time-to-peak threshold best identifies penumbral flow? A comparison of perfusion-weighted magnetic resonance imaging and positron emission tomography in acute ischemic stroke. Stroke. 2004;35:2843–2847. doi: 10.1161/01.STR.0000147043.29399.f6. [DOI] [PubMed] [Google Scholar]
  24. Takasawa M, Jones S, Guadagno JV, Christensen S, Fryer TD, Harding S, Gillard JH, Williams GB, Aigbirhio FI, Warburton EA, Ostergaard L, Baron JC. How reliable is perfusion MR in acute stroke? Validation and determination of the penumbra threshold against quantitative PET. Stroke. 2008;39:870–877. doi: 10.1161/STROKEAHA.107.500090. [DOI] [PubMed] [Google Scholar]
  25. Wintermark M, Flanders AE, Velthuis B, Meuli R, van Leeuwen M, Goldsher D, Pineda C, Serena J, van der Schaaf I, Waaijer A, Anderson J, Nesbit G, Gabriely I, Medina V, Quiles A, Pohlman S, Quist M, Schnyder P, Bogousslavsky J, Dillon WP, Pedraza S. Perfusion-CT assessment of infarct core and penumbra: receiver operating characteristic curve analysis in 130 patients suspected of acute hemispheric stroke. Stroke. 2006;37:979–985. doi: 10.1161/01.STR.0000209238.61459.39. [DOI] [PubMed] [Google Scholar]
  26. Wirestam R, Andersson L, Ostergaard L, Bolling M, Aunola JP, Lindgren A, Geijer B, Holtas S, Stahlberg F. Assessment of regional cerebral blood flow by dynamic susceptibility contrast MRI using different deconvolution techniques. Magn Reson Med. 2000;43:691–700. doi: 10.1002/(sici)1522-2594(200005)43:5<691::aid-mrm11>3.0.co;2-b. [DOI] [PubMed] [Google Scholar]
  27. Wu O, Ostergaard L, Weisskoff RM, Benner T, Rosen BR, Sorensen AG. Tracer arrival timing-insensitive technique for estimating flow in MR perfusion-weighted imaging using singular value decomposition with a block-circulant deconvolution matrix. Magn Reson Med. 2003;50:164–174. doi: 10.1002/mrm.10522. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Cerebral Blood Flow & Metabolism are provided here courtesy of SAGE Publications

RESOURCES